Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Relative Risk01:12

Relative Risk

366
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
366
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

715
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
715
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

412
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes.

Diabetologia·2026
Same author

Cost-Effectiveness of NT-proBNP-Guided Cardiovascular Screening in Chinese Adults With Type 2 Diabetes: Real-World Evidence From the Hong Kong Diabetes Biobank.

Diabetes, obesity & metabolism·2026
Same author

Higher HbA1c Following Younger Age of Transfer From Pediatric to Adult Type 1 Diabetes Services: Data From the Australasian Diabetes Data Network (ADDN) Registry.

Diabetes care·2026
Same author

Young People With Type 2 Diabetes Are Under-Represented in Randomized Clinical Trials.

Diabetes, obesity & metabolism·2026
Same author

Reappraising gestational hyperglycaemia: a manifestation of lifelong glycaemia or a correlation of glycaemic indices across life stages. Reply to Joshi SR, Samajdar SS, Mohan V [letter].

Diabetologia·2026
Same author

Population-scale genomic medicine with the Hong Kong Genome Project.

Nature medicine·2026
Same journal

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Nature medicine·2026
Same journal

Data rights are the missing pillar for modernizing consent in medicine.

Nature medicine·2026
Same journal

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Nature medicine·2026
Same journal

Immune aging biomarkers for clinical trials.

Nature medicine·2026
Same journal

Lassa fever countermeasures gather pace.

Nature medicine·2026
Same journal

Why high scores do not mean application readiness for health AI.

Nature medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 19, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

A microRNA-based dynamic risk score for type 1 diabetes.

Mugdha V Joglekar1, Wilson K M Wong2, Pooja S Kunte2

  • 1Diabetes & Islet Biology Group, Western Sydney University, School of Medicine, Sydney, New South Wales, Australia. m.joglekar@westernsydney.edu.au.

Nature Medicine
|June 5, 2025
PubMed
Summary
This summary is machine-generated.

A new microRNA (miRNA)-based dynamic risk score (DRS) effectively identifies individuals at high risk for type 1 diabetes (T1D). This AI-enhanced score aids in T1D stratification and predicts treatment response, offering a promising tool for early intervention.

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.7K
A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
07:39

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

7.4K

Related Experiment Videos

Last Updated: Sep 19, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.7K
A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
07:39

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

7.4K

Area of Science:

  • Biomarkers and Diagnostics
  • Genomics and Bioinformatics
  • Endocrinology and Metabolism

Background:

  • Early identification of individuals at high risk for type 1 diabetes (T1D) is critical for timely intervention with disease-delaying therapies.
  • Functional beta cell loss is a key characteristic of T1D, making it a target for risk assessment.

Purpose of the Study:

  • To develop and validate a microRNA (miRNA)-based dynamic risk score (DRS) for T1D risk stratification across diverse populations.
  • To assess the predictive capability of the DRS for T1D, future insulin requirements, and treatment efficacy.

Main Methods:

  • Discovery analysis identified 50 miRNAs associated with beta cell loss in T1D.
  • A four-context, miRNA-based dynamic risk score (DRS) was developed using multicenter, multiethnic cohorts (n=2,204).
  • Generative artificial intelligence enhanced the DRS, which was validated on an independent dataset (n=662) and assessed in a clinical trial.

Main Results:

  • The miRNA-based DRS effectively stratified individuals with and without T1D.
  • The enhanced DRS demonstrated strong predictive power for T1D stratification (AUC=0.84).
  • The DRS accurately predicted exogenous insulin requirements post-islet transplantation and distinguished drug responders from nonresponders in a clinical trial.

Conclusions:

  • A novel, AI-enhanced, miRNA-based DRS provides a robust tool for T1D risk stratification.
  • The DRS shows potential for predicting disease progression and treatment response, enabling personalized medicine approaches.
  • This study highlights the utility of machine learning and miRNA signatures in advancing T1D diagnostics and therapeutic strategies.